Out-licensing: Other Therapeutic

Up-to-date access to technology licensing opportunities worldwide.

Out-licensing
Browse

Licensing opportunities

Displaying 11..20 of 55 - per page Previous page Next page
Order by

Butylcholinesterase-Binding Compounds for Monitoring and Inhibiting the Progression of Alzheimer's Disease

These radioactive compounds have the very unique and unprecedented ability to bind very specifically and irreversibly to butyrylcholinesterase (BChE). More

Animal Restraint Jacket

An improved animal restraint jacket designed to protect an implanted vascular catheter or other implanted device in the animal. More

Bone Binding Conjugate for the Treatment of Osteoporosis

Highly effective anabolic treatment of periodontal bony defects with novel prostaglandin E1 complex. More

EUDRAMODE (tm) proprietary oral drug delivery technology platform

EUDRAMODE (tm) is an oral drug delivery technology More

Production process of C4 synthons by biotransformation.

Production process of C3 synthons by biotransformation. More

Medigreen: 1217B- Asthma treatment

1217B is a botanically derived potential drug candidate that inhibits the synthesis of several key pro-inflammatory mediators involved in the pathophysiology of allergic asthma and has been found to improve lung functionality in a mouse model. More

Selenocysteine Mediated Hybrid Antibody Molecules

These hybrid antibody molecules can be engineered with a variety of small synthetic molecules, and the combination of immunogenic properties results in compounds with powerful target destruction or imaging capabilities. More

Medigreen: CA-88-Cancer chemotherapy and radiotherapy auxiliary treatment

CA-88 is a botanically derived auxiliary treatment that has been shown to exhibit healthful benefits for patients undergoing cancer chemotherapy and radiotherapy. More

Protective and Therapeutic Agent for Alcoholic Hepatotoxicity

Naturally occurring compound shown to inhibit and reverse fatty liver. More

Peptide That Prevents Gastrointestinal Infections

A therapeutic peptide that can prevent intestinal infections by increasing the expression of MUC3 by intestinal epithelial cells. More

Displaying 11..20 of 55 - per page Previous page Next page
Order by

Your selection

Therapeutic target: Other therapeutic del

Browse By

Industry sector: Animal health; Biotechnology; Diagnostic; Drug delivery; Drug discovery; Medical device; Pharmaceutical; Research tools
Therapeutic target: Ayuverdic medicine; Chinese medicine; Dietetic; Homeopathy; Iron excess; Kanpo medicine; Other
Development phase: Early Stage; Preclinical; Phase I; Phase I/II; Phase II; Phase III; Phase III/IV; Preregistration; Registered

Products:	Partnering Search	Company Profiling	Deal Negotiation	PL Intelligence	Reports	Comparision
In-licensing:	Latest records	Industry Sector	Therapeutic Target	Search	Profile your company	Pharma partnering
Out-licensing:	Latest records	Industry Sector	Therapeutic Target	Search	Profile your company	Pharma partnering
Companies:	Profiled companies	Industry Sector	Therapeutic Target	Geographic Location	Search	Add your company
Reports:	Biotechnology	Business Development	Management	Market & Sales	Medical Devices	Pharmaceuticals
Jobs:	Pharmaceutical jobs	Browse jobs	Search for jobs	Create your CV	Employer profiles	Post your jobs
Forums:	Talk to an expert	Industry Gossip	Business Development	What's new	Reports	Services
News:	Deals & Alliances	Development	Financial Results	Financings	Intellectual Property	Regulatory
Events:	Pharma events	Calendar	Organizers	Featured events	Search
Articles:	Business Development	Technologies	Events	Legal and regulatory	Therapeutic
Deals:	Industry Sector	Therapeutic Target	Deals Date	Search	Reports	Press releases
About us:	Our Audience	Case Studies	Newsletter	Careers	FAQ	Contact us